通光線纜(300265.SZ):第一期員工持股計劃完成股票購買
格隆匯11月11日丨通光線纜(300265.SZ)公佈,截至2020年11月11日收盤,本次員工持股計劃通過“江蘇信託-通光線纜員工持股1號單一資金信託”以集中競價交易方式累計買入公司股票42.5萬股,佔公司截至2020年11月10日總股本的0.12%,成交均價為人民幣12.24元/股,成交金額為人民幣519.9980萬元。
本次員工持股計劃的資金來源為員工自籌資金及公司按照1:3比例使用的獎勵基金,實際認購的份額為530.67萬份,實際認購份額與股東大會審議通過的擬認購份額不超過532萬份不存在差異。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.